- Previous Close
2,850.00 - Open
2,800.00 - Bid 2,800.00 x --
- Ask 2,900.00 x --
- Day's Range
2,800.00 - 2,900.00 - 52 Week Range
2,700.00 - 4,800.00 - Volume
6,570 - Avg. Volume
4,523 - Market Cap (intraday)
148.76M - Beta (5Y Monthly) 0.43
- PE Ratio (TTM)
18.63 - EPS (TTM)
1.53 - Earnings Date Mar 24, 2025 - Mar 28, 2025
- Forward Dividend & Yield 1.55 (5.44%)
- Ex-Dividend Date Nov 7, 2024
- 1y Target Est
5,100.00
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; Pyrene 1-hydroxypyrene glucuronide (HOP-G) ELISA kit to monitor human exposure to industrial pollutants; and Pyrene (HOP-G) lateral flow kits for monitoring of at-risk individuals without laboratory equipment. It also provides contract SMAs services; and industrial and environmental biomonitoring platform, which reduces the time between sampling and results. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.
www.bioventix.comRecent News: BVXP.L
View MorePerformance Overview: BVXP.L
Trailing total returns as of 3/14/2025, which may include dividends or other distributions. Benchmark is FTSE 100 .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BVXP.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BVXP.L
View MoreValuation Measures
Market Cap
148.76M
Enterprise Value
142.76M
Trailing P/E
18.64
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
11.09
Price/Book (mrq)
12.39
Enterprise Value/Revenue
10.49
Enterprise Value/EBITDA
13.29
Financial Highlights
Profitability and Income Statement
Profit Margin
59.51%
Return on Assets (ttm)
49.17%
Return on Equity (ttm)
67.29%
Revenue (ttm)
13.61M
Net Income Avi to Common (ttm)
8.1M
Diluted EPS (ttm)
1.53
Balance Sheet and Cash Flow
Total Cash (mrq)
6M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
6.91M